K Freese

950 total citations
17 papers, 373 citations indexed

About

K Freese is a scholar working on Epidemiology, Molecular Biology and Hepatology. According to data from OpenAlex, K Freese has authored 17 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 6 papers in Molecular Biology and 6 papers in Hepatology. Recurrent topics in K Freese's work include Liver Disease Diagnosis and Treatment (8 papers), Liver physiology and pathology (4 papers) and Fibroblast Growth Factor Research (3 papers). K Freese is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), Liver physiology and pathology (4 papers) and Fibroblast Growth Factor Research (3 papers). K Freese collaborates with scholars based in Germany, Switzerland and Austria. K Freese's co-authors include Claus Hellerbrand, Anja‐Katrin Bosserhoff, Wolfgang E. Thasler, Tatjana Seitz, Peter Dietrich, A Mahli, Serene M. L. Lee, Anne‐Judith Waligora‐Dupriet, Ina Bergheim and Stéphanie Beutheu and has published in prestigious journals such as Scientific Reports, Journal of Hepatology and British Journal Of Nutrition.

In The Last Decade

K Freese

16 papers receiving 371 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K Freese Germany 9 206 105 58 57 51 17 373
Virginia Gutiérrez‐de Juan Spain 7 181 0.9× 129 1.2× 57 1.0× 44 0.8× 66 1.3× 8 369
Tingying Jiao China 11 230 1.1× 131 1.2× 110 1.9× 56 1.0× 59 1.2× 15 467
Estefanía de Gregorio Spain 8 195 0.9× 144 1.4× 29 0.5× 73 1.3× 62 1.2× 8 470
Roxana U. Miranda Mexico 12 201 1.0× 115 1.1× 37 0.6× 27 0.5× 47 0.9× 14 471
Simon Bucher France 13 138 0.7× 144 1.4× 63 1.1× 36 0.6× 59 1.2× 19 407
Masayasu Jo Japan 9 126 0.6× 150 1.4× 54 0.9× 73 1.3× 97 1.9× 13 452
Chuangpeng Shen China 9 158 0.8× 93 0.9× 42 0.7× 37 0.6× 26 0.5× 15 346
Lianjun Xing China 12 142 0.7× 154 1.5× 28 0.5× 26 0.5× 53 1.0× 23 357
A Mahli Germany 12 193 0.9× 158 1.5× 72 1.2× 27 0.5× 60 1.2× 21 472
Hongjuan Feng China 8 143 0.7× 98 0.9× 54 0.9× 71 1.2× 58 1.1× 9 370

Countries citing papers authored by K Freese

Since Specialization
Citations

This map shows the geographic impact of K Freese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Freese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Freese more than expected).

Fields of papers citing papers by K Freese

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Freese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Freese. The network helps show where K Freese may publish in the future.

Co-authorship network of co-authors of K Freese

This figure shows the co-authorship network connecting the top 25 collaborators of K Freese. A scholar is included among the top collaborators of K Freese based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Freese. K Freese is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Seitz, Tatjana, et al.. (2022). Role of Fibroblast Growth Factor 9 in bile acid homeostasis. Zeitschrift für Gastroenterologie. 60(1). e8–e8. 1 indexed citations
2.
Seitz, Tatjana, Christina Hackl, K Freese, et al.. (2021). Xanthohumol, a Prenylated Chalcone Derived from Hops, Inhibits Growth and Metastasis of Melanoma Cells. Cancers. 13(3). 511–511. 24 indexed citations
3.
Dorn, Christoph, Erwin Gäbele, Frauke Bataille, et al.. (2020). Four-And-A-Half LIM-Domain Protein 2 (FHL2) Deficiency Aggravates Cholestatic Liver Injury. Cells. 9(1). 248–248. 8 indexed citations
4.
Seitz, Tatjana, K Freese, Peter Dietrich, et al.. (2020). Fibroblast Growth Factor 9 is expressed by activated hepatic stellate cells and promotes progression of hepatocellular carcinoma. Scientific Reports. 10(1). 4546–4546. 37 indexed citations
5.
Freese, K, Tatjana Seitz, Peter Dietrich, et al.. (2019). Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro. Cancers. 11(10). 1587–1587. 88 indexed citations
6.
Mahli, A, Tatjana Seitz, K Freese, et al.. (2019). Bone Morphogenetic Protein-8B Expression is Induced in Steatotic Hepatocytes and Promotes Hepatic Steatosis and Inflammation In Vitro. Cells. 8(5). 457–457. 22 indexed citations
7.
8.
9.
Seitz, Tatjana, et al.. (2018). Expression profile of fibroblast growth factors in hepatic stellate cells and experimental models of liver fibrosis. Zeitschrift für Gastroenterologie. 56(1). E2–E89. 1 indexed citations
10.
Dietrich, Peter, K Freese, A Mahli, et al.. (2017). Combined effects of PLK1 and RAS in hepatocellular carcinoma reveal rigosertib as promising novel therapeutic “dual-hit” option. Oncotarget. 9(3). 3605–3618. 29 indexed citations
11.
Jegatheesan, Prasanthi, Stéphanie Beutheu, K Freese, et al.. (2016). Preventive effects of citrulline on Western diet-induced non-alcoholic fatty liver disease in rats. British Journal Of Nutrition. 116(2). 191–203. 77 indexed citations
12.
Mahli, A, K Freese, Andreas Teufel, et al.. (2016). Analysis of molecular mechanisms of 5-fluorouracil-induced hepatic steatosis and inflammation in vitro and in mice. Zeitschrift für Gastroenterologie. 54(12). 1343–1404. 2 indexed citations
13.
Mahli, A, et al.. (2016). Analysis of Molecular Mechanisms of 5-Fluorouracil Induced Steatosis and Inflammation in Vitro and in Mice. Journal of Hepatology. 64(2). S234–S234. 2 indexed citations
14.
Mahli, A, et al.. (2016). Iso-Alpha Acids (IAA) from hops (Humulus lupulus) inhibit hepatic steatosis, inflammation and fibrosis. Zeitschrift für Gastroenterologie. 54(12). 1343–1404. 1 indexed citations
15.
16.
Mahli, A, K Freese, Tobias S. Schiergens, et al.. (2016). Analysis of molecular mechanisms of 5-fluorouracil-induced steatosis and inflammationin vitroand in mice. Oncotarget. 8(8). 13059–13072. 40 indexed citations
17.
Freese, K, et al.. (2015). Increased expression of histone deacetylase 7 during hepatic stellate cell activation promotes pro-fibrogenic gene expression. Zeitschrift für Gastroenterologie. 53(12). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Virginia Gutiérrez‐de Juan Breakdown of academic impact, for papers by Tingying Jiao Breakdown of academic impact, for papers by Estefanía de Gregorio Breakdown of academic impact, for papers by Roxana U. Miranda Breakdown of academic impact, for papers by Simon Bucher Breakdown of academic impact, for papers by Masayasu Jo Breakdown of academic impact, for papers by Chuangpeng Shen Breakdown of academic impact, for papers by Lianjun Xing Breakdown of academic impact, for papers by A Mahli Breakdown of academic impact, for papers by Hongjuan Feng
Rankless by CCL
2026